Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Benefits Pro
49m
Employer plans face GLP-1 anti-obesity drug rebate threats
About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...
Becker's Hospital Review
57m
Why GLP-1s might treat a plethora of conditions
Discover the potential of GLP-1 medications like Ozempic and Mounjaro in treating a wide range of conditions, from diabetes to addiction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
'Harry Potter' star dies
Helene: How to help
Stadiums to serve as shelters
Promotes watch collection
Targeted Black residents?
Pleads not guilty
World's oldest cheese found
Killer gets life sentence
50/50 ball ownership suit
Producing doc on Diddy
More executives leave
Ending password-sharing
NC board removes 747K
On Secret Service failures
Fake Biden robocalls fine
Chinese submarine sank
Urgent safety alert for 737s
NIH finds misconduct
WI duplicate ballot flap
Boxes to distribute Narcan
Heads to US-Mexico border
ISR targets Hezbollah HQ
US charges three Iranians
Farmers want flu vaccine
Fed inflation gauge cools
Related topics
Ozempic
Middle East
Eli Lilly and Company
Novo Nordisk
Viking Therapeutics
Feedback